OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.82% | 13.76% | 18.78% | 24.18% | 25.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.82% | 13.76% | 18.78% | 24.18% | 25.90% |
| Cost of Revenue | -29.17% | -4.98% | 9.42% | 15.17% | 17.84% |
| Gross Profit | 7.10% | 24.23% | 23.94% | 29.57% | 30.84% |
| SG&A Expenses | -5.41% | -11.00% | -16.70% | -8.12% | -8.93% |
| Depreciation & Amortization | -1.63% | -1.38% | -0.07% | 2.36% | 20.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.37% | -4.78% | -0.78% | 6.99% | 8.10% |
| Operating Income | 188.95% | 578.83% | 302.41% | 192.49% | 138.77% |
| Income Before Tax | 173.11% | 159.67% | 136.00% | 105.15% | 64.68% |
| Income Tax Expenses | 266.22% | 500.43% | 154.76% | 118.36% | 107.13% |
| Earnings from Continuing Operations | 146.62% | 144.36% | 125.52% | 100.14% | 44.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 146.62% | 144.36% | 125.52% | 100.14% | 44.91% |
| EBIT | 188.95% | 578.83% | 302.41% | 192.49% | 138.77% |
| EBITDA | 87.50% | 1,291.75% | 1,108.09% | 423.17% | 227.63% |
| EPS Basic | 145.90% | 143.69% | 124.93% | 100.11% | 46.40% |
| Normalized Basic EPS | 555.03% | 217.23% | 161.33% | 115.26% | 88.49% |
| EPS Diluted | 141.33% | 140.86% | 123.08% | 99.69% | 46.28% |
| Normalized Diluted EPS | 521.59% | 212.75% | 158.13% | 114.54% | 88.16% |
| Average Basic Shares Outstanding | 1.44% | 1.41% | 1.43% | 2.00% | 4.07% |
| Average Diluted Shares Outstanding | 2.91% | 4.28% | 4.31% | 3.91% | 4.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |